Bovine Blood Plasma Derivatives Market Size & Share Analysis - Growth Trends and Forecasts (2024 - 2029)

The Bovine Blood Plasma Derivatives Market Report is Segmented by Derivatives (Immunoglobulin, Fibrinogen, Bovine Serum Albumin, Fetal Bovine Serum, Newborn Calf Serum, Thrombin, and Others), End-User Industry (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, Food Industry, and Other End Users), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The Report Offers the Value (in USD) for the Above Segments.

Bovine Blood Plasma Derivatives Market Size & Share Analysis - Growth Trends and Forecasts (2024 - 2029)

Bovine Blood Plasma Derivatives Industry Overview

The bovine blood plasma derivatives market is fragmented in nature due to the presence of several companies operating globally and regionally. The competitive landscape includes an analysis of a few international and local companies that hold the market shares and are well known, including LAMPIRE Biological Labs Inc., Merck KGaA, SeraCare, MP Biomedicals, Thermo Fisher Scientific, TCS Biosciences, ROCKY MOUNTAIN BIOLOGICALS, Bovogen Biologicals, Kraeber & Co GmbH, Auckland BioSciences Ltd, and Tissue Culture Biologicals.

Bovine Blood Plasma Derivatives Market Leaders

  1. Merck KGaA

  2. SeraCare

  3. Thermo Fisher Scientific

  4. TCS Biosciences

  5. Tissue Culture Biologicals

  6. *Disclaimer: Major Players sorted in no particular order
Bovine Blood Plasma Derivatives Market Concentration